Adverse events154

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 154

Type	Event	Organ system	Group	Affected	At risk
other	Abdominal pain	Gastrointestinal disorders	Treatment (Pazopanib Hydrochloride) Patients Receive Pazopanib Hydrochloride PO QD on Days 1-28	4	32
other	Activated partial thromboplastin time prolonged	Investigations	Treatment (Pazopanib Hydrochloride) Patients Receive Pazopanib Hydrochloride PO QD on Days 1-28	2	32
other	Akathisia	Nervous system disorders	Treatment (Pazopanib Hydrochloride) Patients Receive Pazopanib Hydrochloride PO QD on Days 1-28	1	32
other	Alanine aminotransferase increased	Investigations	Treatment (Pazopanib Hydrochloride) Patients Receive Pazopanib Hydrochloride PO QD on Days 1-28	19	32
other	Alkaline phosphatase increased	Investigations	Treatment (Pazopanib Hydrochloride) Patients Receive Pazopanib Hydrochloride PO QD on Days 1-28	6	32
other	Allergic reaction	Investigations	Treatment (Pazopanib Hydrochloride) Patients Receive Pazopanib Hydrochloride PO QD on Days 1-28	1	32
other	Alopecia	Skin and subcutaneous tissue disorders	Treatment (Pazopanib Hydrochloride) Patients Receive Pazopanib Hydrochloride PO QD on Days 1-28	9	32
other	Anemia	Blood and lymphatic system disorders	Treatment (Pazopanib Hydrochloride) Patients Receive Pazopanib Hydrochloride PO QD on Days 1-28	10	32
other	Anorexia	Metabolism and nutrition disorders	Treatment (Pazopanib Hydrochloride) Patients Receive Pazopanib Hydrochloride PO QD on Days 1-28	5	32
other	Anxiety	Psychiatric disorders	Treatment (Pazopanib Hydrochloride) Patients Receive Pazopanib Hydrochloride PO QD on Days 1-28	4	32
other	Appendicitis	Gastrointestinal disorders	Treatment (Pazopanib Hydrochloride) Patients Receive Pazopanib Hydrochloride PO QD on Days 1-28	1	32
other	Arthralgia	Musculoskeletal and connective tissue disorders	Treatment (Pazopanib Hydrochloride) Patients Receive Pazopanib Hydrochloride PO QD on Days 1-28	4	32
other	Arthritis	Musculoskeletal and connective tissue disorders	Treatment (Pazopanib Hydrochloride) Patients Receive Pazopanib Hydrochloride PO QD on Days 1-28	4	32
other	Aspartate aminotransferase increased	Investigations	Treatment (Pazopanib Hydrochloride) Patients Receive Pazopanib Hydrochloride PO QD on Days 1-28	19	32
other	Ataxia	Nervous system disorders	Treatment (Pazopanib Hydrochloride) Patients Receive Pazopanib Hydrochloride PO QD on Days 1-28	3	32
other	Back pain	Musculoskeletal and connective tissue disorders	Treatment (Pazopanib Hydrochloride) Patients Receive Pazopanib Hydrochloride PO QD on Days 1-28	6	32
other	Bloating	Gastrointestinal disorders	Treatment (Pazopanib Hydrochloride) Patients Receive Pazopanib Hydrochloride PO QD on Days 1-28	1	32
other	Blood bilirubin increased	Blood and lymphatic system disorders	Treatment (Pazopanib Hydrochloride) Patients Receive Pazopanib Hydrochloride PO QD on Days 1-28	7	32
other	Blurred vision	Eye disorders	Treatment (Pazopanib Hydrochloride) Patients Receive Pazopanib Hydrochloride PO QD on Days 1-28	6	32
other	Cholesterol high	Investigations	Treatment (Pazopanib Hydrochloride) Patients Receive Pazopanib Hydrochloride PO QD on Days 1-28	2	32

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01436227/events

API reference For AI assistants

Adverse events154

Sources 3

Read this list from software.